COVID-19 Risk Assessment tool is here

Since 2012, Infermedica has developed sophisticated artificial intelligence tools for patient triage and symptom checking which have been relied upon by professionals and used by over 5 million patients worldwide. With the unrelenting virulence of the geographic spread of the SARS-CoV-2 virus, Infermedica has stepped up to the challenge and has centralized all of their expertise and efforts.

Over the past two weeks our teams worldwide have been working tirelessly on the release of our technological response to the global threat of the SARS-CoV-2 virus. Using all available distribution channels, a carefully curated COVID-19 pre-screening solution for patients, compliant with WHO guidelines, is being deployed; our goal being to shift the burden of triage from health care practices, government-organized assessment centres and emergency departments while helping all patients to quickly and accurately self-evaluate their risk of infection of the virus and properly navigate them to the appropriate venue for care.

Embed, share, or use the API

The COVID-19 Risk Assessment tool is unquestioningly offered free of charge to existing Infermedica clients and to the general public, providing:

  • Embedding code. Standalone capacity allowing it to be embedded in any website or any app.
  • Product updates. Enhanced interview flow that can be enabled in all Infermedica products.
  • New API. API protocol driven, ready to be integrated into a third-party solution.
  • Symptomate update. Added functionality of Symptomate, Infermedica’s showcase symptom checking app.

The content behind the tool is based on the official guidelines established by the WHO and was meticulously implemented by Infermedica’s medical team, who is continuously updating it to address the latest WHO and CDC reports and findings.

The tool is currently available in over 20 languages. Chinese, Croatian, Czech, Dutch, English, Estonian, French, Georgian, German, Malay, Polish, Portuguese (Brazilian), Russian, Slovak, Spanish, Spanish (Latin America), Spanish (Mexico), Tamil, Turkish, Ukrainian.

To learn more, check our website for the COVID-19 Risk Assessment tool.

Organizations from all over the world are joining us

There are already more than 20 healthcare and insurance organizations from more than 15 countries that decided to join us on the mission to stop the COVID-19 outbreak and implement the tool, including PZU Zdrowie, Global Excel, International Medical Center, Dovera, Dr. Sintomas, GdziePoLek, and iWylecz.

What’s next

We’re not stopping here. As we continue to update the COVID-19 Risk Assessment tool with the latest WHO and CDC findings, we are forging ahead with continued enhancement of the tool, together with translating it to more languages to make it quickly available to as many people as possible.

The entire global community is embroiled in this public health crisis. The end is still not in sight. Undoubtedly, we can expect many more weeks and months seeing not only governments, institutions and companies, but also every single individual rally, offering what they can to abate this pandemic. There will be highs and lows. But, together we will vanquish it.

Stay strong and stay well,

Piotr Orzechowski
CEO, Infermedica